Our work is entirely funded by private donations – we receive no money from government. Your money will help us continue funding research into vitiligo and supporting people affected by the condition.
LY4005130 antibody treatment for nonsegmental vitiligo
Official title: A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Status: Recruiting now
Description:
Eli Lilly and Company plans to enroll about 66 participants. LY4005130 is an experimental antibody that neutralizes XCL1 and XCL2 signals linked to harmful CD8 T cells. It is designed to reduce the immune attack on melanocytes and encourage repigmentation. Possible risks include infusion reactions, headache, and infections; its full safety profile is not yet known. People ages 18 to 75 may qualify. The study is recruiting at 35 listed sites across 5 countries.
Start date: April 14, 2026
Completion date: September 01, 2027
Organizer: Eli Lilly and Company
Contact: Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or
Tel.: 1-317-615-4559
Email: LillyTrials@Lilly.com
Clinical Trial Alerts
Sign up and be the first to know about updates on this trial.
FAQOther Questions
- Vitiligo and Pregnancy
Pregnancy with vitiligo? The good news: vitiligo itself doesn’t make pregnancy unsafe. Most women stay stable (some even improve), though flares can pop up after birth — usually...
- What joining a clinical trial actually looks like?
Pediatric vitiligo trials · Taking part Cream twice a day, scheduled visits and the practical questions every mother asks before committing the family calendar. The studies disc...
- Is it possible to stop the progression of vitiligo?
While it's not always possible to quickly stop vitiligo progression, there are some treatments that can help slow or halt the spread of the condition in many cases: Corticostero...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.